4//SEC Filing
Wright Richard M. 4
Accession 0001646423-25-000007
CIK 0000744218other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:17 PM ET
Size
16.5 KB
Accession
0001646423-25-000007
Insider Transaction Report
Form 4
Wright Richard M.
Other
Transactions
- Exercise/Conversion
Common Stock
2025-11-13$9.02/sh+6,876$61,997→ 27,709 total - Exercise/Conversion
Common Stock
2025-11-13$10.38/sh+26,672$276,855→ 54,381 total - Exercise/Conversion
Common Stock
2025-11-13$22.48/sh+15,750$354,060→ 70,131 total - Sale
Common Stock
2025-11-13$24.00/sh−49,298$1,183,177→ 20,833 total - Exercise/Conversion
Incentive Stock Option
2025-11-13−6,876→ 0 totalExercise: $9.02Exp: 2028-06-13→ Common Stock (6,876 underlying) - Exercise/Conversion
Incentive Stock Option
2025-11-13−15,750→ 7,875 totalExercise: $22.48Exp: 2032-06-16→ Common Stock (15,750 underlying) - Exercise/Conversion
Incentive Stock Option
2025-11-13−26,672→ 0 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (26,672 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.05 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]As of June 13, 2022, the option is fully vested.
- [F3]As of June 18, 2024, the option is fully vested.
- [F4]25% vested on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001646423
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:17 PM ET
- Size
- 16.5 KB